000 | 01965 a2200517 4500 | ||
---|---|---|---|
005 | 20250514025826.0 | ||
264 | 0 | _c20020627 | |
008 | 200206s 0 0 eng d | ||
022 | _a1079-9907 | ||
024 | 7 |
_a10.1089/107999002753536220 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aVerdun, E | |
245 | 0 | 0 |
_aAutoantibodies in multiple sclerosis patients before and during IFN-beta 1b treatment: are they correlated with the occurrence of autoimmune diseases? _h[electronic resource] |
260 |
_bJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research _cFeb 2002 |
||
300 |
_a245-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xadverse effects |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge of Onset |
650 | 0 | 4 |
_aAutoantibodies _xbiosynthesis |
650 | 0 | 4 |
_aAutoimmune Diseases _ximmunology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInterferon beta-1a |
650 | 0 | 4 | _aInterferon beta-1b |
650 | 0 | 4 |
_aInterferon-beta _xadverse effects |
650 | 0 | 4 |
_aLiver Diseases _xepidemiology |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMultiple Sclerosis _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRecombinant Proteins _xadverse effects |
650 | 0 | 4 | _aReference Values |
700 | 1 | _aIsoardo, G | |
700 | 1 | _aOggero, A | |
700 | 1 | _aFerrero, B | |
700 | 1 | _aGhezzi, A | |
700 | 1 | _aMontanari, E | |
700 | 1 | _aZaffaroni, M | |
700 | 1 | _aDurelli, L | |
773 | 0 |
_tJournal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research _gvol. 22 _gno. 2 _gp. 245-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1089/107999002753536220 _zAvailable from publisher's website |
999 |
_c11817270 _d11817270 |